The rise of private travel vaccines in the UK can be attributed to several factors, including the increasing number of people travelling abroad and the growing awareness of vaccine importance (much attributed to the COVID-19 pandemic).

In the UK, people usually get their vaccinations done through the NHS, particularly new-borns/young children. However, not all vaccines are available and not all people are eligible for vaccines on the NHS. Now that there is more awareness of the importance of vaccines, the private market has started to see growth with people looking to pay through private means for their vaccines.

People receiving treatment through private healthcare isn’t a new concept to the UK but it is starting to grow in popularity, as more people start to find new ways to take their health into their own hands.

The private healthcare industry is about to face both impactful changes and growth opportunities in the coming years. However, there is a significant lack of data available for businesses in the sector, meaning it’s hard to understand exactly what and where the opportunities are.

With chronic diseases on the rise, the demand for healthcare solutions is transforming the pharmaceutical industry. The global demand to meet these medical needs means that every year brings new and anticipated drug approvals.

Self-pay healthcare continues to be on the rise, so we can’t ignore it. As the proportion of consultants’ income from self-pay hits a new record high, we think this trend is likely to continue growth - even as we move into more certain times, post COVID pandemic.

We spoke to Georgina Bishop, Head of Self-pay at The London Clinic, who shared her insights and knowledge of the changing market and how the industry can adapt to make self-pay more accessible. Georgina is passionate about delivering a seamless journey for patients from start to finish, and for the professional healthcare community.